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The symptoms of malaria are brought about by blood-stage parasites, which are established when 
merozoites invade human erythrocytes. Our understanding of the molecular events that underpin 
erythrocyte invasion remains hampered by the short-period of time that merozoites are invasive. To 
address this challenge, a Plasmodium falciparum gamma-irradiated long-lived merozoite (LLM) line 
was developed and investigated. Purified LLMs invaded erythrocytes by an increase of 10–300 fold 
compared to wild-type (WT) merozoites. Using an integrated omics approach, we investigated the basis 
for the phenotypic difference. Only a few single nucleotide polymorphisms within the P. falciparum 
genome were identified and only marginal differences were observed in the merozoite transcriptomes. 
By contrast, using label-free quantitative mass-spectrometry, a significant change in protein 
abundance was noted, of which 200 were proteins of unknown function. We determined the relative 
molar abundance of over 1100 proteins in LLMs and further characterized the major merozoite surface 
protein complex. A unique processed MSP1 intermediate was identified in LLM but not observed in WT 
suggesting that delayed processing may be important for the observed phenotype. This integrated 
approach has demonstrated the significant role of the merozoite proteome during erythrocyte invasion, 
while identifying numerous unknown proteins likely to be involved in invasion.
Merozoites have been a focus of malaria vaccine research and development for nearly a half a century. A strong 
basis for this interest has focused on original work by Cohen et al.1 and reproduced by Druilhe et al.2 who demon-
strated that passive transfer of IgG from individuals hyper-immune to P. falciparum to children clinically ill from 
P. falciparum malaria conferred protection against severe disease. Human immunoglobulins against parasite 
proteins including those involved in red blood cell (RBC) invasion3 and presumptively against members of the 
PfEMP1 family involved in sequestration of parasitized erythrocytes4 are both likely to have contributed to this 
clinical outcome. From the many known proteins involved in erythrocyte invasion, only a few have been assessed 
in human phase 1 studies examining safety and immunogenicity5–9 and only three candidates have been evalu-
ated in human phase 2 biological efficacy trials10–12 including controlled human malaria infection studies13,14. 
Unfortunately, only limited or no significant protective benefit has been observed in these studies.
In the 1970s, it was discovered that the merozoites of P. knowlesi, a simian malaria parasite, could be purified 
using cell-sieving techniques and the resultant merozoites were invasive with an observed half-life of approxi-
mately twenty minutes15,16. This discovery aided in a number of significant observations involving ultra-structural 
analyses of the merozoite and mechanistic studies of erythrocyte invasion (see review Bannister et al.17). 
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Interestingly, P. knowlesi has since been identified as the fifth malaria parasite to infect humans18. These early 
studies with P. knowlesi, and subsequent studies involving P. falciparum without purified invasive merozoites, and 
other apicomplexan parasites have facilitated our current understanding of erythrocyte invasion by merozoites as 
a well-orchestrated and rapid process (approx. 1 min.) that relies on precise signaling and multiple receptor-ligand 
interactions19,20.
In the past four decades’ efforts to study cell-sieve purified P. falciparum merozoites like those of P. knowlesi 
have failed to produce significant numbers of invasive merozoites. Methods for isolating P. falciparum mero-
zoites have been reported previously but their invasive properties remained to explored21. Alternative strategies 
have been developed to evaluate merozoite invasion using drug treated P. falciparum parasites and differential 
centrifugation to enrich for populations of invasive merozoites that may still contain mature intra-erythrocytic 
parasites22. Boyle et al.23 used centrifugation to study how heparin-like molecules block P. falciparum merozoite 
invasion. Singh et al.24 used a similar technique to analyze the role that Ca+2 flux plays in merozoites during 
erythrocyte invasion. It may also be possible to develop methods to isolate invasive merozoites by regulating key 
events required for schizont maturation25 which may help by preventing premature activation. Enhanced molec-
ular and structural biology tools also have improved our mechanistic understanding of known invasion ligands 
such as the merozoite surface protein-1 complex26, the erythrocyte binding proteins (EBA) EBA-175 and EBA-
14027,28, and apical membrane antigen-120,29. However, many proteins remain within the P. falciparum proteome, 
and in particular the merozoite proteome, with unknown functions that may be involved in erythrocyte invasion.
To identify novel proteins likely involved in invasion as well as improve our basic understanding of erythro-
cyte invasion, an integrated omics approach was used to study a γ-irradiated parasite line that was selected for 
long-lived merozoite (LLM) phenotype and that was amenable to cell-sieve purification for the isolation of viable 
merozoites as compared to the parental wild-type (WT) parasite line. While limited changes were observed in the 
open reading frames of the LLM genome and in the LLM transcriptome relative to WT, label-free quantitative 
proteomics identified unique changes in protein abundance of over 400 known and unknown proteins in LLM 
relative to WT. Using this label-free quantitative approach, we established for the first time the relative quanti-
tation of a merozoite proteome that included over 1,100 proteins. Of interest was an observation of an apparent 
delayed processing of two merozoite proteins in the merozoite surface protein complex of the LLM compared to 
WT merozoites, which highlights the importance of protein stability and its relationship to erythrocyte invasion.
Results
Cell-sieving and collection of long-lived merozoites. P. falciparum long-lived merozoites were puri-
fied using a cell-sieving apparatus as described in Fig. 1A that permitted continuous culture of purified schizonts 
in a temperature and gas controlled chamber overlaid on a polycarbonate membrane with 2 µm pores. A contin-
uous forward or reverse flow of media was controlled electronically with a peristaltic pump while the culture was 
stirred with an overhead impeller. The net egress of media was 0.3 mL/minute. Maturing, segmented schizonts 
were retained by the membrane while free merozoites passed through the 2 µm pores (Fig. 1A, Giemsa stain). 
Merozoites were collected in the effluent at room temperature (~22 °C) in batches of pooled merozoites at approx-
imately 10–15 minute intervals. Merozoites were collected for transcriptomic or proteomic studies as shown in 
Fig. 1B. On a population basis, the invasion efficiency of the LLMs ranged from 8–30% (Fig. 1B), indicating that 
the LLM phenotype had a prolonged viability. This was also confirmed by direct examination by electron micros-
copy of invading LLM (Fig. 1C). Live cell imaging of LLM invasion indicated that the invasion kinetics were 
similar to what was previously reported for other P. falciparum strains (Fig. 1D). Furthermore, merozoites from 
this parasite line were used previously to study the role of the AMA1-RON2 interaction during invasion29. It is 
worthy to note that the variation in the invasion efficiencies could reflect the differences in the maturation stage 
of the schizonts placed in the cell sieve despite efforts to control this by tightly synchronizing the cultures. Having 
established that a significant proportion of the purified merozoites from this selected line retain invasiveness, 
samples were collected for transcriptomic or proteomic studies to identify the molecular determinants of these 
invasive merozoites30.
Comparison of the WT and LLM genomes. To establish whether changes in invasion efficiency in LLM 
parasites were due to genomic changes, we generated genome sequences of the WT and LLM parasites using 
Illumina Next Generation Sequencing. We first generated a genome sequence for the WT FVO line, using bio-
informatic approaches to iteratively convert the 3D7 genome into a FVO genome using the reads from the WT 
line (see Materials and Methods). This is essential because the reference P. falciparum genome is derived from 
the 3D7 strain, which is of African origin and is likely to differ significantly from the FVO strain, which is of 
Southeast Asian origin. Mapping reads from either the WT or LLM parasites against 3D7 would introduce map-
ping errors, confounding our ability to call variants specific to one line or the other. Once an FVO WT genome 
had been generated, the LLM reads were mapped against it, and variants called (see Methods) for all open reading 
frames, excluding regions of high variability corresponding to genes associated with PfEMP1, rifins and stevors 
and non-coding regions. The γ-irradiated selected LLM parasites had only two single nucleotide polymorphisms 
(SNPs) in the open reading frames of those proteins evaluated in LLM versus WT. The gene ID: PF3D7_1007200, 
which encodes for a putative rhoGAP GTPase, was mutated at nucleotide position 1123 from AAA:TAA which 
introduced a stop codon at amino acid position 375 thus eliminating about 35% of the C-terminal end of the 
native protein. As a result, the putative rhoGAP GTPase was terminated within the carboxyl-terminus of the 
putative rho GTPase-activating protein domain. In the gene encoding PF3D7_1361800, a conserved protein with 
an unknown function that is expressed during schizogony, a gene mutation corresponding to an amino acid 
substitution R to I was noted at nucleotide position 7454 AGA:ATA. While uncharacterized, PF3D7_1361800 
contains Armadillo like repeats found in another P. falciparum invasion associated protein that localizes to the 
rhoptry organelles31. The homologue of this gene appears to be essential for asexual growth in a genome-scale 
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genetic screen in P. berghei32. Given the timing of expression and apparent essentiality in a related Plasmodium 
species, this gene and its encoded protein warrants further investigation for a role in P. falciparum merozoite 
invasion. There was also one reversion (Gene ID: PF3D7_0700900, position 341 TGG:TGA) observed in the 
pseudogene encoding a RESA-like protein (see Supplemental Dataset S1). The open reading frame (ORF) for the 
WT genome sequences were used to develop a protein database for use in subsequent proteomic analysis.
Comparison of the WT and LLM transcriptomes. The transcriptomes of WT and LLMs were com-
pared by microarray on commercial Affymetrix chips using three or four biological replicates, which are separate 
unique biological samples collected from a single experiment. The samples were taken from a single experiment 
at the beginning, middle and end of optimal RBC invasion. In Fig. 1B, an example of the sampling times for two 
of the biological replicates are shown. Even though individual merozoite samples were collected at defined inter-
vals throughout the length of each collection, the timing of the individual sample collection was not considered 
in the analysis. Minimal significant changes were identified as shown in the heat map comparing the individ-
ual biological and technical replicates (Fig. 2A and Supplemental Dataset S2). Only three P. falciparum mRNAs 
(PF3D7_0425000, PF3D7_0522400 and PF3D7_1253300) analyzed both by DNA microarray and QPCR method 
were significantly correlated (p < 0.05) (Fig. 2B). PF3D7_0425000 codes for a stevor-like exported protein and 
PF3D7_1253300 codes for a PHISTa family protein that is unlikely to be involved in invasion. PF3D7_0522400 
codes for a ~112 kDa protein containing two membrane spanning regions and is present in all Plasmodium spe-
cies. Unfortunately, none of these proteins were identified in the proteomic studies described below. An analysis of 
the 3D7 sequence arrayed on the chip and WT for gene coverage demonstrated a conservation of about 97% (data 
not shown). The limited differences observed between WT and LLM transcriptomes (Fig. 2A and C) may suggest 
post-transcriptional or translational effects involved in the regulation of the observed invasion phenotype in LLM.
Due to the limited differences observed for the purified merozoites and to better understand whether transcrip-
tional differences could be detected, a study was performed comparing WT to LLM synchronized early schizonts 
(n ≈ 4 nuclei) that controlled for many experimental variables including time, temperature and method. One set 
of biological replicates was compared with five technical replicates. The samples were analyzed on an Affymetrix 
GeneChip Plasmodium/Anopheles containing the P. falciparum genome; no proteomic study was performed in 
Figure 1. Cell-sieve purification and erythrocyte invasion of purified long-lived merozoites (LLM) and 
wild-type (WT) merozoites. (A) Schematic of cell-sieving process that yields purified, invasive merozoites. 
(B) Invasion efficiency of various lots of LLM and WT merozoites as well as the identification of the source 
of merozoite material used in the characterization of the transcriptome, proteome or both. (C) Electron 
microscopic observation illustrating the various stages of invasion using purified LLM merozoites. (D) 
Quantitation of the invasion dynamics using live cell imaging. The number of individual events observed for 
each step is indicated below (n) and the error bars represent standard deviation (SD). “Time post-inoculation 
of cell-sieve” refers to sequential batches of merozoites that are collected in the effluent post cell-sieving. 
Abbreviation “Jun”: junction formation. Scale bars, in panel A: 10 µM and panel C: 1 µm.
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parallel due to technical issues created by hemolysis of RBCs. After establishing a reasonable correlation within the 
cell cycle of the WT and LLM early schizonts (3 hours) (Supplemental Fig. S2), which appears similar with respect 
to the age range described by Lemieux et al.33 the transcription profiles of WT and LLM early schizonts were 
assessed. In contrast to the observations made for merozoites, early schizonts were observed to contain transcrip-
tional differences (Supplemental Fig. S3A and B, and numerical data in Supplemental Dataset S3). Although RNAs 
for many of the merozoite genes encoding proteins involved in merozoite invasion of RBCs were not transcribed 
during this early stage of schizont development, we could assess the transcript abundance for the merozoite sur-
face protein-1 (MSP) protein complex (MSP1, MSP6 and MSP7), which demonstrated no significant difference 
for MSP7. A lower transcript abundance for MSP6 in LLM (~2-fold, p < 0.001) and a higher transcript abundance 
of MSP1 (~2-fold, p < 0.001) in LLM (Supplemental Dataset S3) was discovered. Further study will be required 
to determine if these observed changes in transcript abundance in early schizonts (n ≈ 4 nuclei) affects the levels 
of protein and therefore their downstream function in free merozoites. It is clear from previous studies that tran-
script levels are not necessarily correlative with protein translation and abundance34,35.
Figure 2. Transcriptional analysis comparing cell-sieve purified WT and invasive LLMs (10 × 12, respectively) 
on an Affymetrix chip. (A) Heat map showing transcriptional analysis of WT and LLM when evaluated using 
three pairs of biological replicates comprised of three or four technical replicates (includes samples shown in 
Fig. 1B, WT1 & 2, and LLM1 & 2). (B) Confirmation of transcriptional changes by QPCR for three transcripts 
identified in the transcriptional analysis to be significantly different (p < 0.05). (C) PCA showing clustering of 
WT and LLM biological and technical replicates. Error bars in panel B represent standard error of the mean.
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Quantitative proteomics of WT vs LLM merozoites. Next, we examined the relative protein abun-
dance of WT merozoites vs. LLM merozoites using a label-free quantitation method, designated here as MSE 
(multiplexed data acquisition) and we used TransOmics™ for our analysis of the protein data. Three technical 
replicates were identified from the single paired biological replicate using the WT or LLM merozoite invasion 
curves, pooled and processed as described in the Experimental Procedures (Fig. 1B). The biological replicate 
for WT and LLM is identified as WT1 and LLM1 with an overall invasion efficiency of about 20% for LLM 
compared to <1% for WT merozoites (Fig. 1B). The two proteomic data sets were normalized to five “consti-
tutively expressed” proteins, which were (PF3D7_0406100 (V ATPase subunit B), PF3D7_0520900 (adenosyl-
homocysteinase), PF3D7_0624000 (hexokinase), PF3D7_1115600 (peptidyl-prolyl cis-trans isomerase) and 
PF3D7_1117700 (RAN GTPase)) (Supplemental Fig. S4). These five proteins also were identified to have minimal 
differences in their mRNA expression levels in the merozoite transcriptome data (Supplemental Dataset S2). To 
enhance the selectivity and sensitivity of low abundance proteins, a 5-fractional design was used to provide better 
separation of the tryptic peptides36. Protein abundance was calculated using total peptide intensity (summing 
all non-conflicting peptide intensities for each protein), which identified 981 proteins as present in both WT 
and LLM (Supplemental Dataset S4). Principal components analysis (data not shown) and a correlation analysis 
(Supplemental Fig. S5) of the identified proteins indicated unique clustering of the WT and LLM merozoites, sug-
gesting there are distinct groups of differentially abundant proteins between the non-invasive and invasive mero-
zoite populations, respectively. Using the criteria defined in TransOmics™ for protein identification, 981 proteins 
were identified in both WT and LLM merozoites as high confidence hits (Supplemental Dataset S4). Among these 
981 proteins, based on a correlation analysis with the expression profiles, 446 proteins had significant differences 
in their protein abundance between WT and LLM merozoites (ANOVA p < 0.05). The most significantly affected 
proteins with a >20% or >40% change in abundance are highlighted in the volcano plot generated with log2 fold 
changes in protein abundance versus minus log10 p-values (Fig. 3A). Furthermore, protein differences of ~15% 
were sufficient to exert biological effects on the ability of parasites to establish infection in previous studies of 
malaria infection of liver cells37. Following these criteria, we discovered 86 proteins in higher abundance in LLM 
and 137 proteins in higher abundance in WT merozoites.
Two proteins of interest that were found in higher abundance in the LLM merozoites relative to WT include 
the kinase PKA and the phosphatase Calcineurin, two enzymes shown to play an important role during merozoite 
invasion38–40. In addition, proteins involved in motility and invasion-related functions, such as GAP50, MSP2, 
Figure 3. Comparative analysis of the abundance of common and unique proteins identified between WT 
and LLM merozoites by label-free quantitative analysis using TransOmics™ or PLGS. (A) Volcano plot of 
all quantified proteins from WT and LLM set displaying the relationship between statistical significance and 
percentage change of each protein. The log2 ratio (x axis) was plotted against the −log10 p-value (y axis). 20% 
and 40% changes are highlighted in red and blue color respectively. Gray circle represents either less than 20% 
change or not significant. Triangle represents five IDs used for normalization. A q value threshold of 0.2 (dashed 
horizontal line) and >1.5-FC (vertical dashed lines) are shown where open circles are differentially abundant 
proteins with small q values and large FCs. (B) Proteins uniquely identified in WT and LLM parasites by PLGS.
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MSP7-like protein and EBA-17541–44 were found to be in higher abundance. Two other proteins, Sera 6, a cysteine 
protease that is activated prior to merozoite egress45 and plasmepsin X, an aspartic protease46, also were found to 
be significantly higher in the LLM merozoites compared to WT, raising the possibility that increased amounts of 
these proteases may play a role during merozoite invasion. Another group of proteins that appear to be higher in 
LLM merozoites relative to WT are the components that associate with the ribosomal machinery of the parasite. 
In contrast, the non-invasive WT merozoites relative to LLM contained higher levels of the food vacuole pro-
teases falcilysin, falcipains 2a, 2b, 3 and plasmepsins III, IV47. Finally, there were several proteasome components 
and stress response proteins that were in higher abundance in WT merozoites in comparison to LLM, which may 
indicate some form of a stress response.
Data analysis using TransOmics™ relies on identification of peptides/proteins in both LLM and WT mero-
zoites. It is conceivable that there could be proteins that are uniquely present in either LLM or WT merozoites that 
are missed due to the all or none factor in the comparison. Therefore, we quantitated proteins using PLGS, which 
is a quantitation based on the top 3 ionizing peptides for each protein identified in at least 2 out of the 3 technical 
replicates. Through this more inclusive process, we identified 33 unique proteins in either WT (7 proteins) or 
LLM (26 proteins) relative to each other (Fig. 3B and Supplemental Dataset S5). Comparative analysis of these 
proteins against previous published proteomics studies found in PlasmoDB indicated that 30 out of 33 proteins 
have been previously detected in asexual stage parasites. These observations may reflect differences between LLM 
and WT merozoites in proteins present that are relatively in low abundance. Interestingly, and specific to our 
study, 3 of the 33 proteins were identified for the first time in LLM merozoites and therefore, these proteins could 
represent novel proteins that function during merozoite invasion of the RBC.
Relative protein quantitation of LLMs and implications for protein complexes. For our first 
attempt at relative quantitation of the merozoite proteome, we used LLMs due to their enhanced biological activ-
ity. The individual quantity of each protein was calculated using the intensity of the top-3 most abundant peptides 
(Top3) using ProteinLynx Global SERVER™ (PLGS) 2.5 as described by Silva et al.48 where quantitation was 
performed relative to a protein standard. Quantitative proteomic profiling (Fig. 1B, LLM3) was performed with 
5 technical replicates using a 10-fractional design. A total of 1,106 proteins were quantitatively identified corre-
sponding to approximately 25,824 peptides with an average of 23 peptides per protein and an average coverage 
of 42% across the proteome. A minimum of 3 peptides per protein was necessary for quantitation. The dynamic 
range of those proteins ranged from 171 femtomoles to 862 attomoles (Fig. 4A). The most abundant protein 
identified was the major merozoite surface protein 1 (MSP1) whereas the least abundant protein quantified was 
a conserved protein designated PF3D7_1439600 (Supplemental Dataset S6) which is reported to be involved 
in merozoite invasion and is associated with the Inner Membrane Complex49. The median number of moles of 
protein was 19.18 femtomole.
To attempt to validate the PLGS data set, the known relationships within a ribosomal complex were used to 
evaluate the quantitative relationships between the 69 ribosomal proteins observed in LLMs (Fig. 4A and B)50–52. 
A complete set of protein-protein association data for ribosomes was extracted from the STRING database53. The 
association data e.g., protein-protein interactions between the ribosomes, curated from several sources including 
experimental data, text mining, co-expression analysis, co-occurrence analysis, etc. were then imported into the 
network visualization and analysis tool within Cytoscape54. The protein quantitation data were mapped onto 
the ribosome network and active modules (highly connected subnetworks that have relatively higher levels of 
combined protein quantity compared to other potential subnetworks) were identified using the Cytoscape plugin 
jActiveModules. Network statistics including the degree (total number of associations) of a node or protein in 
the network and its total number of associations were computed using Cytoscape default parameters. Correlation 
analysis was performed using the statistical software package R between the degree of a node - a protein - and 
Figure 4. Characterization of the relative molar quantitation of the LLM proteome. (A) Molar abundance of all 
merozoite proteins identified in at least 3 out of 5 technical replicates. (B) Ribosomal network analysis showing 
statistical association between 61 ribosomal proteins.
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its protein quantity. The degree sorted circle layout (Fig. 4B) showed a pattern of decreasing quantitation of the 
ribosomal proteins with respect to decreasing degree of the nodes, suggesting that the level of protein quantity 
measured in this experiment correlates with their need to form a functional association with other proteins. This 
initial observation between the degree - number of associations and the protein quantitation required further 
statistical analysis of the association between the variables ‘degree’ and ‘quantitation’. We performed this addi-
tional analysis by using Pearson’s product-moment correlation, which showed a positive correlation of 0.381183 
between the variables ‘degree’ and ‘quantitation’. A linear regression analysis also showed that the correlation 
between the variables degree and quantitation is significant at the level of 0.05 (p-value 0.00123). The results of 
our ribosome protein data analysis suggest that the protein quantitation reported here is useful for the analyses of 
peptide mapping, protein processing, and protein-protein or protein-rRNA relationships.
The presence of protein complexes in merozoites is well described41,55–59. However, the roles for many of these 
complexes remains unclear. One major complex exposed on the merozoite’s surface is a multi-protein complex 
composed of MSP1, MSP6 and MSP755,56. MSP1 is considered to be involved with binding to protein(s) on the 
erythrocyte surface26. Each of these MSPs appear to be proteolytically processed during egress as well as dur-
ing RBC invasion60 and specifically MSP1 processing has been shown to enable parasite egress from RBCs60. 
Whether MSP1 processing as observed in LLM merozoites affects their ability to invade RBCs prior to release 
remains to be seen. The proteins and/or their proteolytically processed fragments are non-covalently associated 
with MSP1, which is glycosylphosphatidylinositol anchored within the merozoite membrane61. We assessed the 
molar composition of the proteins in this complex as well as another leading protein, known as the apical mem-
brane antigen-1 (AMA1). Good peptide coverage was observed for the three proteins within the MSP1 complex: 
64%, 58% and 59% for MSP1, MSP6 and MSP7, respectively (Supplemental Dataset S6). The relative molar con-
centrations of MSP1, MSP6 and MSP7 in LLM were 171.2, 33.4 and 63.2 fmoles, respectively. The presence of 
each MSP1 proteolytic fragment was assessed for MSP1 p83, p38 and p42, in which each protein appeared in 
about an equal molar concentration: 117.64, 136.67 and 143.42 fmoles, respectively, while p30 appeared much 
lower at 44.22 fmoles. MSP6 and MSP7 are also proteolytically processed56,62 and therefore, the peptide coverage 
for these proteins was mapped using the LLM proteome (Fig. 5A). In general, the peptide coverage for MSP6 
indicated that the amino-terminal end, which is reported to be cleaved and lost56, appeared to be more abundant 
in LLM than WT based on the peptide coverage analysis (Supplemental Fig. S6: PF3D7_1035500). In the same 
analysis, the amino-terminal end of MSP7 appeared to have been processed and lost, which is consistent with 
earlier findings62.
We analyzed the peptidomes of individual proteins identified in both WT and LLM merozoites using the 
peptide abundance data for the 446 proteins identified in the TransOmics data and flagging those peptides whose 
abundances were statistically significantly different between WT and LLM merozoites (Supplemental Fig. S6). 
MSP1 (PF3D7_0930300), an abundant merozoite surface protein involved in invasion, had the most peptides 
detected, and it is used as an example here (Fig. 5E, and Supplemental Fig. S6). In the carboxyl-terminal half 
of MSP1 corresponding to p110, of the 7 peptides with intensities >2.5 × 106 and that showed statistically sig-
nificant differences in peptide abundance between WT and LLM, 5 out of the 7 peptides were more abundant 
in LLM. This difference might be caused by more rapid or premature endogenous proteolytic processing of the 
carboxy-terminus of MSP1 in WT, and seemed to correspond to a relative increase in the carboxy-terminal MSP1 
p110 processed product detected for LLM in immunoblots (see below and Fig. 5B and C). In contrast, at the 
amino-terminal end of MSP1 (p83) although a very abundant peptide (intensity 2.0 × 107 in LLM, near residue 
440) was increased 2.2-fold in LLM relative to WT; there was no marked difference in the immunoblots. The sim-
ilarity between WT and LLM for MSP1 p83 on immunoblots might be explained if there were a post-translational 
modification in p83 other than endogenous non-tryptic cleavage, such as a change in phosphorylation that 
altered peptide recovery or detection by MS.
To address the composition and processing of the MSP1 complex using an alternative approach, quantitative 
Western blotting was performed using MSP1, MSP6 and MSP7 specific polyclonal and/or monoclonal antibodies 
(mAb). A two-color fluorescence system was used to allow a comparison between potentially variable condi-
tions versus “a control” believed to be unchanging. First, an analysis of MSP1 using mAb 1G3, which recognizes 
MSP142 and rabbit MSP142 specific antiserum showed similar reactivity patterns and detected full-length MSP1 
and the processed fragments (MSP142 and MSP119) (Fig. 5B). An additional band was recognized by both of the 
two MSP1 specific reagents in LLM at approximately 110 kDa (MSP1110), but not in WT merozoites, thereby 
indicating that this fragment is devoid of the p83 protein domain (Fig. 5B). These results held true in subsequent 
repetitive blots (Fig. 5C). Using MSP6 and MSP7 rat or rabbit specific antiserum, the expected protein fragments 
for MSP6 and MSP7 were detected (Fig. 5C, left panels, respectively). The banding intensities of MSP1110 and 
MSP6FL were noted to be different between the WT and LLM lysates. To assess these differences quantitatively, 
the Western blots were performed independently three times using equimolar amounts of the merozoite lysates. 
MSP1, MSP6 and MSP7 band intensities were measured (Fig. 5D). The initial observations for the different stain-
ing intensity for MSP1110 and MSP6FL appeared to be confirmed. No changes were observed for MSP722 (Fig. 5D, 
lower right panel). The MSP7 antisera also was known to detect MSP1 due to its parasite derived origin.
Discussion
The process of P. falciparum merozoite invasion of erythrocytes is a complex cascade of events that are time 
sensitive. Even though our understanding of particular steps in the overall processes have improved17,20, gaps in 
our knowledge remain. In an effort to further our understanding of merozoite biology, a γ-irradiated selected 
parasite line, identified as a long-lived merozoite (LLM) line, was developed with the aim of extending the lon-
gevity of a purified merozoite population for analysis of invasion of erythrocytes. The aim was clearly achieved 
and the LLM line was shown to invade erythrocytes by a 10 to 300 fold greater rate than the WT parent line 
(Fig. 1). Furthermore, this enhanced invasion phenotype was amenable to cell-sieve purification in a manner 
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Figure 5. Analysis of the major merozoite surface complex: MSP1, MSP6 and MSP7. (A) Molecular schematics 
of the MSP1, MSP6, and MSP7 proteins showing peptide coverage (red colored regions) and proteolytic 
processing sites (arrows) and specificity of MSP1 antibodies. (B) Infrared immunoblot analyses of purified 
WT or LLM lysates showing staining for MSP1 full-length and processed fragments thereof using polyclonal 
rabbit (Rb) antiserum or mAbs 89.1 or 1G3. In this panel, Rb anti-MSP1 serum (red) and mAb 1G3 (green) 
were performed together while 89.1 was reacted alone. (C) Infrared immunoblot analysis of purified WT or 
LLM lysates showing staining for MSP1 full-length and process fragments thereof using polyclonal rabbit (Rb) 
antiserum or mAb 1G3 in combination with rat (Rt) anti-MSP6EDK or Rb anti-MSP7 antisera, respectively. (D) 
Quantitative analysis of intact and proteolytic fragments of MSP1, MSP6, MSP7 from three independent blots, 
similar to those shown in panel C. Error bars represent standard deviation of three independent quantitated 
blots. (E) Peptide abundance changes in MSP1 protein between WT and LLM. Statistically significantly peptides 
(p-value < 0.05) are highlighted with a black asterisk above their position, peptides with fold change over the 
threshold (>25%) of one strain over another are denoted with a grey asterisk above their position and peptides 
that are both statistically significant and have a fold change above the threshold (>25%) are designated with 
a red asterisk (for WT) and blue asterisk (for LLM). A comparison of the WT and LLM MSP1 specific band 
intensities for the full-length, 42 kDa and 19 kDa fragments, noted within panels B and C, showed a variance of 
approximately 20%.
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that is similar to what was described for the simian malaria parasite, P. knowlesi15,16. A significant body of work 
was possible in the past due to this innate suitability of P. knowlesi merozoites to be purified and used for RBC 
invasion studies17. In a similar manner, purified P. falciparum LLM were used in the studies that demonstrated 
the role of RON2 binding to AMA1 for activation of merozoite invasion29.
Our comparative DNA sequence analysis of the ORFs coding about 80% of the genes showed limited 
changes between LLM and WT parasites. Three SNPs were observed: 1) a stop codon likely causing truncation 
of PF3D7_1007200, which is a putative rhoGAP GTPase, 2) a reversion from a FVO-like phenotype to that of 
3D7 in PF3D7_0700900, a pseudogene for a RESA-like protein, and 3) an amino acid substitution from R to I 
in an armadillo like protein, now known as the glideosome-associated connector (GAC), that is up-regulated in 
schizogony and is designated as PF3D7_1361800. It is important to note that variants were called only in open 
reading frames, due to the difficulty of mapping reads to the highly AT-rich intergenic regions of the P. falciparum 
genome. We cannot rule out the presence or contribution of mutations in the 20% of the genes not sequenced 
or in regulatory DNA regions controlling gene transcription or translation that might account for the differ-
ences in protein expression between LLM and WT merozoites. It is also possible that epigenetic control mecha-
nisms63 may have produced the LLM phenotype. However, the genomic data does make it clear that even though 
γ-irradiation and selection resulted in limited genomic sequence changes, genetic engineering could modify WT 
parasites to produce each of these individual mutations in order to examine their separate and combined effects 
on invasion phenotype. The truncation of PF3D7_1007200, a putative rhoGAP GTPase, deleted 213 residues of 
its carboxy-terminus and is likely to alter its activity and localization. In platelets, decreased RhoGAP activity 
increased platelet adhesion64. The identification of one SNP within PF3D7_1361800, the glideosome-associated 
connector (GAC), is worthy of further investigation, especially since GAC is thought to play a central role coor-
dinating gliding motility and invasion65. It seems a remarkable coincidence that in a yeast two-hybrid assay, 
PF3D7_1361800 (GAC) interacted with PF3D7_1007200 (RhoGAP)66.
It is clearly understood that transcriptional changes occur during the 48 hour intra-erythrocytic cycle of para-
site development67,68. These transcriptional changes, in general, correspond to the parasite’s demands for growth, 
which involve the need to restructure the erythrocyte cytosol during early trophozoite development and in addi-
tion, the transcription of genes involved in late schizogony that are related to merozoite egress and invasion. To our 
knowledge, no transcriptional profiling of purified invasive merozoites has been performed to date. We compared 
the transcriptomes of LLM to that of WT parasites. We discovered that in the microarray analysis, only four tran-
scripts were identified to be significantly different in their expression patterns between the two merozoite types 
with our observation of an increased transcript abundance in LLM between 1.58–2.32 (p < 0.05), which were a 
S-adenosylmethionine-dependent methyltransferase (PF3D7_0522300), a putative thiamin-phosphate pyrophos-
phorylase (PF3D7_0614000), an unknown Plasmodium exported protein (PHISTa) (PF3D7_1253300) and a con-
served protein with an unknown function (PF3D7_0522400). Whether these small changes in the transcription 
level of these genes are a part of the LLM phenotype remains to be determined. Furthermore, it is unclear whether 
the low numbers of genes that are transcriptionally different are an accurate assessment of the transcriptional 
environment, or due to RNA turnover, or perhaps are driven by the inherent variation introduced by our sampling 
methods. Finally, in our analysis of the transcriptional profiles of WT and LLM parasites during early schizogony 
in vitro (n ≈ 4 nuclei), a significant number of transcriptional differences were observed. How these transcriptional 
differences, if at all, impact on the observed phenotype of LLM merozoites relative to WT merozoites is unclear. 
However, investigation of the WT and LLM transcriptional profiles using mature schizonts (n = 8–16 merozoites/
cell) appears warranted in order to understand if there are notable transcriptional differences leading up to the 
development of a segmented schizont. Importantly, our studies indicate that active transcription after merozoite 
release from schizonts may not contribute significantly to new proteins being made for invasion.
Proteomic studies of nearly all developmental stages of P. falciparum have been conducted including sporo-
zoites, trophozoites and/or merozoites and gametocytes69–71. However, none of these investigations were able 
to assess changes in protein abundance between a non-invasive WT population of merozoites and a purified 
population of merozoites with a significant percentage of invasive forms. The unique property of long-lived 
merozoites that we describe here has enabled us to quantitate changes in protein abundance between WT and 
LLM merozoites. There are some known proteins present in higher abundance in LLM relative to WT mero-
zoites. Some of these proteins are PF3D7_0918000 (PfGAP50), PF3D7_1222700 (PfGAP45), PF3D7_0501300 
(skeleton-binding protein 1), and PF3D7_0616500 (TRAP-like protein), which have been shown to play a crit-
ical role in maintaining the parasite skeleton, inner membrane complex (IMC), actin myosin motor function, 
functional invasion of RBCs by the parasite72–74 and gliding locomotion of the parasite which is required for 
successful invasion75. Two previous studies have implicated a role for the TRAP/MIC2-like proteins MTRAP 
and PTRAMP41,76. Both of these proteins were in higher abundance in LLM merozoites relative to WT mero-
zoites. Other invasion specific proteins such as the membrane skeletal protein IMC1-related (PF3D7_0304100), 
P38, a 6-cysteine protein (PF3D7_0508000), and the erythrocyte binding antigen-140 (PF3D7_1301600) were 
uniquely identified in LLM, but absent in the WT merozoites. Apart from known invasion ligands, functionally 
unknown or annotation deficient proteins were uniquely detected or identified in higher or lower abundance in 
LLM relative to WT merozoites.
The P. falciparum genome encodes approximately 5,300 proteins77. Here we have reported the first relative 
quantitation of a merozoite proteome that contains over 1,100 proteins, for which the protein molar abundance 
spans three orders of magnitude (Fig. 4A). Others have previously shown that the dynamic range of protein con-
centrations spans more than three, five and in some cases seven orders of magnitude in microbial78, yeast79 and 
human proteomes80 respectively. Before we addressed specific questions, we aimed to qualify the relative molar 
concentrations. Work by Hardy in 197550 suggested that overall there is a relationship between the abundance 
of ribosomal proteins in E. coli using metabolically labeled proteins. Thus, our observation that there was a cor-
relation between ribosomal protein abundance for the 61 ribosomal proteins within the network analysis using 
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Cytoscape provides a basis of support for the overall relative molar concentrations established for the other 1,039 
asexual proteins. Thus, this quantitated data set is likely a reasonable approximation for the first relative compo-
sition of a merozoite proteome.
Next, we evaluated the molar composition of the most abundant merozoite surface protein complex com-
prised of MSP1, MSP6 and MSP7 and evaluated their known processing events by quantitative Western blot 
and protein/peptide abundance by MSE. Two unique observations were made. First, using the relative molar 
concentrations by MSE, we approximated the stoichiometry for the three proteins that may form a complex as 
5:1:2. MSP1 may be in a molar excess and available to form complexes with other proteins such as MSPDBL1 and 
MSPDBL281. A second observation we made was an apparent delay in processing in LLM for MSP1 and MSP6. 
Peptide abundance at the p110 carboxy-terminal end of MSP1 was increased in LLM relative to WT, correlating 
with immunoblots that showed a native p110 form of MSP1 only in LLM. Similarly, immunoblots showed that 
LLM had a much greater ratio of full length to processed MSP6. These results suggest that the enhanced viabil-
ity of LLM may be due, in part, to delayed proteolytic processing of merozoite proteins involved in invasion. 
Another difference in the peptide abundance of the p83 amino terminus of MSP1, however, was not correlated 
with changes on immunoblots, but may indicate a difference between LLM and WT in other post-translational 
modifications, such as phosphorylation (which was not studied here), which might nevertheless affect invasion. 
These observations open the door to further examination of the effects of the amounts and timing of various 
post-translational modifications (endogenous proteolysis, phosphorylation, etc.) on the ability of merozoites to 
maintain their invasiveness.
In summary, we have demonstrated that LLM purified by cell-sieving retained a significant proportion of 
invasive merozoites, which could be purified in large numbers. Using these purified long-lived merozoites (LLM) 
in comparison with the WT control, an integrated omics approach demonstrated only marginal changes in the 
open reading frame of the parasite genome as well as marginal changes in the parasite’s transcriptome. However, 
significant changes were observed in the proteome that may lead to the identification of the functions of unknown 
proteins and highlights the importance of protein stability and processing in the process of erythrocyte invasion.
Materials and Methods
Parasite Culture, Isolation of Merozoites and Efficiency of RBC Invasion. A line of P. falciparum 
FVO derived from HDGFP82 previously selected for prolonged survival of free merozoites through the process 
of γ-irradiation and selection of blood stage parasites maintained in a low hematocrit suspension culture in vitro 
was used in this study (Haynes, unpublished data). The parent WT line HDGFP did not fluoresce well or produce 
gametocytes, and it appeared to be more like FVO than the expected 3D782 based first on restriction enzyme 
fingerprinting and then on sequencing. Parasite-infected RBCs were cultured as described83–85 and synchronized 
by temperature cycling84. RBCs were obtained from the WRAIR Clinical Trials Center (Silver Spring, MD) and 
sera from the Interstate Blood Bank (Memphis, TN). Briefly, the long-lived merozoite (LLM) line was generated 
by γ-irradiating (150 rad from a Cesium-137 source) about 4 × 108 WT (HDGFP) trophozoite-infected RBC and 
then culturing in liquid suspension84 at constant 37 °C with decreasing RBC concentrations (Hcts) to exert selec-
tive pressure for long-lived merozoites by limiting contact between merozoites and RBC. Hematocrits (initially 
4% Hct) were gradually adjusted downward to maintain a growth rate of at least 2-fold per cycle. The selective 
pressure for long lived merozoites was exerted by increasing the distance between the suspended cells at low 
Hct and thus increasing the time-to-contact of merozoites with RBC. After about 6 months of sub-cultures, the 
irradiated suspension-selected line could maintain growth rates of about 2-fold per cycle with only 0.3% Hct in 
suspension cultures, had twice the growth rates of WT at 1% Hct in suspension cultures, and was able to produce 
viable invasive merozoites as purified by cell sieving – thus the low Hct suspension-selected line was now called 
the LLM line. Subsequently, both WT and LLM lines were maintained by passage in suspension cultures in a tem-
perature cycling incubator (Mid) that maintained synchronous growth on a 48-hour schedule86 however, 1% Hct 
cultures were used to maintain the LLM line, in contrast to the standard 4% Hct used to maintain the WT line. 
Before merozoites were purified, cultures were expanded in 4% Hct suspension cultures to allow the purification 
of about 1 × 109 schizonts. Expansion cultures generally began as 6 large flasks of 45 ml 4% Hct per 150 cm2 flask, 
which was increased to 12 large flasks of 60 ml 1.5% Hct 2–3% trophozoites with the final media change about 
18 hours before the Percoll-alanine purification. The growth rates for WT and LLM were similar when grown in 
4% Hct suspension cultures, 8.8 (n = 5) and 10.4 (n = 3) per cycle, respectively (p = 0.07).
Merozoites from these LLM or WT lines were purified as follows. From this point on, Low Bicarbonate 
Medium (LBM) was used for all washes and cultures. LBM is similar to RPMI-NaOH, pH 7.486 except that LBM 
was adjusted to 300 mOsm using NaCl and water, and the only bicarbonate was supplied by adding 10% serum. 
LBM was not gassed but was exposed to the ambient atmosphere. Expanded cultures of mature schizont-infected 
RBCs (with also about 1–3% newly invaded ring-infected RBC) were centrifuged at 400 g, resuspended in LBM, 
and purified on a Percoll-alanine gradient at 1200 × g for 10 min at 37 °C (Haynes, unpublished). The schizonts 
(generally 7–15 × 108 with >90% at more than eight nuclei) were aspirated from the 40%/70% Percoll-alanine 
interface, washed with LBM, resuspended in 3 ml LBM and returned to culture briefly at 37 °C while schizonts 
were enumerated by hemocytometer. About 1 × 109 schizonts in 6 ml LBM were transferred to a water-jacketed 
chamber (Fig. 1A) fitted with a 2 μm polycarbonate membrane and allowed to mature and rupture while being 
pumped out at 0.3 ml per minute and collected at room temperature (22–24 °C) into one tube every 10 minutes. 
Parasite culture in the gently stirred filter chamber was constantly supplied with fresh ungassed LBM as needed. 
For proteomics, microarrays and western blots, the collected merozoites (generally about 1 × 108/ml) were passed 
through a 0.4 ml cushion of 5% sucrose in 1/2 strength PBS (a mixture of 1 part 10% sucrose with 1 part PBS) in 
a 1.5 ml tube at 1500 × g for 7 mins, followed by a PBS wash at 5000 × g for 10 mins. Merozoite pellets were stored 
at −80 °C until further use. Due to processing and handling times, each merozoite collection of WT or LLM was 
performed on independent days.
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Merozoite invasion rates were evaluated by mixing merozoite samples (about 3 minutes after the termina-
tion of each 10 minute collection) with RBC in LBM followed by flow cytometry following general procedures 
similar to that previously described86. A 0.3 ml aliquot from each merozoite sample was mixed with 0.3 mL of 
1% RBC (1.0 × 108 RBC/mL) in a pre-warmed 1 mL NUNC tube, which was sealed and incubated at 37 °C for 
1.5 hours with 35 rpm end-over-end mixing. To prevent the loss of merozoites during flow cytometry stain-
ing, PBS-EDTA-glucose86 GIA buffer for staining was mixed 1 part with 3 parts 10% sucrose to produce 7.5% 
sucrose-GIA buffer. Small aliquots (1–10 µl) of cultures, merozoites, or invasion mixtures were stained for flow 
cytometry by mixing with 50 µl of fluorescent HY dyes (10 µg/mL Hoechst 33342 and 2.5 µM Yo-Pro1 in 7.5% 
sucrose-GIA buffer) for 90 min in 5 mL tubes at 37 °C with gentle shaking. Stained samples were diluted 10-fold 
with 7.5% sucrose-GIA buffer and stored at room temperature (storage at 4 °C caused loss of merozoites) for 
up to 1 day before analyzing with a B-D LSR flow cytometer. Forward scatter was used to gate merozoites and 
RBC. RBC that did not fluoresce were considered uninfected. RBCs that fluoresced only with the permeant dye 
(Hoechst 33342) were considered invaded. RBC that fluoresced with both the permeant and impermeant dye 
were considered to have either adherent or adjacent merozoites. Aliquots of merozoites only were stained with 
HY dyes and diluted with a known number of normal RBC to aid in their enumeration by flow cytometry and 
used to calculate the number of merozoites per ml (generally about 1 × 108/ml from about 1 to 3 hours after 
beginning the cell sieving). The percentage of invasive merozoites was calculated as (# invasion events / # total 
merozoites) × 100. When merozoite invasion was calculated by counting the numbers of merozoites by hemo-
cytometer and the number of newly invaded RBCs (ring stage parasites) on Giemsa stained smears, it correlated 
well with flow cytometry.
For electron microscopy, purified LLM were mixed with pre-warmed RBCs and incubated at 37 °C for 30 sec-
onds. Samples were fixed with ice cold fixative (2% paraformaldehyde, 0.01% glutaraldehyde in 1X PBS) and kept 
on ice for 30 min and subsequently processed for electron microscopy as described29.
Invasion dynamics of the LLM were monitored by mixing purified mature LLM schizonts with RBCs. The 
Dvorak chamber was placed in a 37 °C stage incubator with 5% CO2 and individual invasion events were recorded 
using a Leica SP2 confocal microscope.
Genome sequencing. P. falciparum FVO (HDGFP) parasites identified as wild-type (WT) were cultivated 
as mentioned in the above section84. Parasite culture with 8–10% of parasitemia at schizont stage was lysed with 
0.1% saponin and the genomic DNA was isolated using standard phenol/chloroform extraction and concen-
trated by salt precipitation87. PCR-free libraries88 with a fragment size of 450 bp were prepared and sequenced 
on a Illumina HiSeq. We obtained 20–32 million paired end 76 bp reads for the two lines, giving an average 
Plasmodium genome coverage of 60–90x for each line. All data is available in the European Nucleotide Archive, 
with accession numbers ERS038923 (WT or HDGRP) and ERS038924 (LLM or HHSS). To generate a WT paren-
tal genome, we iteratively mapped reads from the WT line against the Pf3D7 version2 reference, and corrected the 
differences for five iterations using iCORN89, transforming the Pf3D7 genome into an FVO genome. The new WT 
sequence was annotated by transferring the annotation from Pf3D7 using RATT90. Finally, reads from the WT 
line were mapped against the new, annotated FVO genome using SMALT (SMALT - http://www.sanger.ac.uk/
science/tools/smalt-0) and bases supported by less than 10 reads were transformed to n’s. To identify genomic 
variants in the LLM line, we mapped the reads from these lines using SMALT. Variation was called with mpileup 
from the SAMtools package91.
RNA extraction, DNA microarray target preparation. The purified merozoites were washed in 
PBS, centrifuged at 4 °C, cell pellets were flash frozen, and stored at −80 °C. RNA extractions were performed 
with Qiagen 96-well Rneasy system (Qiagen, Valencia, CA). Briefly, frozen merozoite pellets from parent and 
select lines were resuspended in 300 µL Qiagen RLT buffer containing 1% β-mercaptoethanol (BME) and passed 
through a QiaShredder (Qiagen, Valencia, CA) homogenization column by centrifugation at 21,000 × g for 2 min-
utes. All samples were brought to a final volume of 700 μL with RLT buffer containing 1% BME. Four-hundred 
ninety μL of 100% ethanol was added to each sample, mixed and purified using RNeasy 96 kit (Qiagen, Valencia, 
CA) including DNase I treatment with 27 Kunitz units of DNAse 1 (Qiagen, Valencia, CA) for 15 minutes at 
room temperature to remove contaminating genomic DNA. RNA concentrations and integrity were assessed by 
A260/280 spectrophotometry and by analysis on the Agilent 2100 Bioanalyzer.
Amplified antisense single-stranded cDNA (ss-cDNA) targets were prepared from an aliquot and used as tem-
plate for the WT-Ovation RNA Amplification System (Nugen, San Carlos, CA). To monitor cDNA synthesis and 
amplification, each RNA sample was spiked with a mixture of four B. subtilis polyA-tailed mRNAs (dap, lys, thr, 
trp genes). Amplified ss-cDNAs were generated following the manufacturer’s recommended protocol, quantified 
using A260/280 spectrophotometer and analyzed on Agilent’s 2100 BioAnalyzer. The ss-cDNAs were fragmented 
and labeled following Nugen’s FL-Ovation cDNA Biotin Module V2 protocol (Nugen, San Carlos, CA) prior to 
Affymetrix DNA microarray hybridization.
Microarray processing. Hybridization, fluidics and scanning were performed according to standard 
Affymetrix protocols (http://www.affymetrix.com) for the GeneChip® Plasmodium/Anopheles Genome Array. 
GeneChip Operating Software (GCOS v1.4, http://www.Affymetrix.com) was used to convert the image files to 
cell intensity data. The cell files were input into Partek Genomics Suite software (Partek, inc. St. Louis, Mo.) and 
quantile normalized to produce the principal components analysis (PCA) graphs. An ANOVA was performed 
within Partek to obtain multiple test corrected p-values using the false discovery rate (FDR) method92 and was 
combined with fold change values for each comparison of interest.
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Estimation of asexual parasite cell-cycle using microarray data. A reference dataset68 representing 
46 individual time points of the complete P. falciparum (HB3 strain) asexual intra-erythrocytic developmental 
cycle and our own data set were input into Partek® Genomics Suite™ software (v6.6 Copyright © 2012 Partek 
Inc., St. Louis, MO, USA). All arrays were scaled to 1250. The average signal across replicates was used for refer-
ence time points represented by multiple arrays. The reference oligo identifications were mapped to Affymetrix 
probe sets using P. falciparum open reading frame identifications. Normalized signal intensities from mapped 
probe sets were used to calculate the maximum correlation coefficient across reference time points as an estimate 
of the specific intra-erythrocytic developmental cycle. To validate this method, a separate time series93 with pub-
lished intra-erythrocytic developmental cycle time points of 0, 8, 16, 24, 32, 40, and 48 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE14524) demonstrated accuracy within 3 hrs.
QPCR validation. Three P. falciparum mRNAs were selected for Q-RT-PCR validation analysis – 
PF3D7_1253300, PF3D7_0522400, and PF3D7_042500. Constitutively expressed reference mRNAs were selected 
from the DNA microarray results by ranking probe-sets based on expression level (present call) and coefficient 
of variation (CV). The optimal reference mRNA was selected based on three criteria: mRNA expression in all 
samples, low CV across treatments and gene-function. Putative glutamate-tRNA ligase mRNA was selected as a 
reference mRNA (PF130257). All Q-RT-PCR probe and primer sets were designed using Beacon Designer 8.12 
(PREMIER Biosoft International, Palo Alto, CA). Due to low GC-content of P. falciparum genome sequence, over 
30 nucleotide long oligo sequences were selected during the design to allow normal annealing and extension tem-
peratures during QPCR (Supplemental Dataset S7). Remaining Q-RT-PCR template preparation, PCR conditions 
and analysis are described in detail elsewhere94.
Sample Preparation for LC/MS. Samples were prepared as previously described95. Briefly, 4 × 108 
merozoites were suspended in 50 mM ammonium bicarbonate (pH 8.5) with 0.06% RapiGest™ (Waters, p/n 
186001861). Samples were digested by sequencing-grade trypsin and incubated at 37 °C for overnight. Before 
the digestion, 5 µl of 100 mM DTT was added to reduce disulfide bonds at 60 °C for 30 minutes and then free 
cysteine residues were alkylated with 5 µl of 300 mM iodoacetamide at room temperature for 30 minutes in the 
dark. Trifluoroacetic acid (0.05% v/v) was used to quench the enzymatic reaction and degrade the RapiGest SF. 
The sample protein mixtures were centrifuged at 13,000 rpm for 10 min and the supernatant was transferred into 
another vial. The pH of the samples was adjusted to pH 10 by adding 5 µL of 1 N NH4OH for effective trapping 
on the 1st dimension column. Samples were spiked with 25 fmol/µl alcohol dehydrogenase before loading the 
nanoACQUITY UPLC® for peptide analysis via LC/MSE.
NanoUPLC/MS Configuration. Tryptic peptides from the complex samples were separated by using 
2-dimensional (2D) liquid chromatography. A 2D nanoACQUITY UPLC® system coupled with an online Synapt 
G2 or Synapt G2-S quadrupole time-of-flight (Q-TOF) mass spectrometer (Waters, Corp., Milford, MA) was 
operated in a positive ion, data-independent acquisition mode called alternate scanning LC-MS (LC/MSE) analy-
sis. MassLynx™ 4.1 software was used to operate the nano UPLC/MS system. The 2D system was configured with 
three columns; i) first dimension high pH reversed phase trapping (or fractionation) column (300 µm × 50 mm 
XBridge™ BEH130 C18 5 µm), ii) second dimension trapping column (80 µm × 20 mm Symmetry® C18 5 µm) 
and iii) second dimension reversed phase analytical column (75 µm × 150 mm HSS T3 1.8 µm). Twenty mM 
ammonium formate (pH 10), and acetonitrile were used as mobile phases A and B respectively for 1st dimension 
fractionation at 2 µl per minute. High pH fractionation of the tryptic peptides from the complex samples was per-
formed either in a 5 or 10 fraction format. For a five-fraction experiment, 11.1, 14.5, 17.4, 20.8, and 45.0% mobile 
phase B steps were used, whereas for a 10 fraction experiment, 6.9, 10.4, 12.1, 13.5, 14.7, 15.9, 17.3, 18.8, 20.9 and 
45.0% steps were used. Fractionated peptides were then trapped onto the second-dimension trap column follow-
ing 1:10 dilution with 2nd dimension mobile phase A (0.1% formic acid, FA, in water), which also acidifies the 
peptides. The 2nd dimension mobile phase B was acetonitrile, 0.1% FA. Each group of fractionated peptides were 
subsequently separated on the second-dimension analytical column with a 90 min. gradient (3–40% B). 200 fmol/
µl [Glu1]-fibrinopeptide (GFP) in 25% ACN, 0.1% FA was used as the lock mass solution with a flow rate of 0.5 µl/
min using the reference sprayer of the nanoLockSpray source. The mass spectrometers were operated with capil-
lary voltage of ~3.0 kV, source temperature 130 °C, and cone voltages 35/30 V on the Synapt G2 and Synapt G2-S, 
respectively. The low and elevated energies used during the LC/MSE experiment were 6 V and 15–35 V (ramped), 
with 1 second/scan. Spectra were recorded from m/z 50 to 1990, and samples were run in quadruplicate.
MSE data set analysis. The LC/MSE data were processed and searched using ProteinLynx Global SERVER™ 
(PLGS) version 2.5 to match the spectra to peptide in the sequence database of the ORFs generated from genome 
sequencing of the P. falciparum WT line. Protein Identifications <250,000 Da were obtained by searching WT 
parasite protein database appended with alcohol dehydrogenase protein sequence. The ion detection, cluster-
ing and normalization were processed using PLGS 2.5 as described earlier48,96. Processed spectra for all frac-
tions for each run were merged independently using PLGS 2.5 merge tool. For MSE, the search was performed 
using the following parameters: a minimum of five fragment ions per peptide and a minimum of nine fragment 
ions per protein, a minimum of one peptide match per protein and a maximum of one missed trypsin cleavage. 
Furthermore, we used (i) Carbamidomethylation (Cys) as fixed modification; (ii) Deamidation (NQ), Oxidation 
(M) and acetylation (N terminus of the protein) as variable modifications; and (iii) a protein false discovery 
(FDR) rate of 10%. The protein false discovery rate was determined automatically in PLGS by searching the ran-
domized and reversed P. falciparum (WT) database. Finally, MSE outputs of the separate runs were merged using 
Microsoft Excel. Protein identification was considered accurate when a protein (paralog) was assigned based on 
at least two proteotypic peptides. Proteins that were certified with one peptide were accepted at a peptide-score 
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above 6 in addition to filtering at a FDR of 10%. Additional data analysis was performed using Spotfire Decision 
Site Version 9.1.2 and Microsoft Excel.
Protein quantification using TransOmics™. For quantitative analyses, the LC/MSE data acquired on a 
Synapt G2 mass spectrometer were processed using TransOmics™, which transformed the raw high-resolution 
profile data with lock-spray mass-calibration into a custom TOIP format and extracted peptide intensity features 
from MSE data. The LC/MSE chromatograms of all samples and replicates acquired datasets were aligned against 
a chosen reference run i.e., fraction one of each injection which was arbitrarily chosen as the best representative, 
due to highest resolution and therefore presumed to have the lowest number of missing data points. Retention 
time alignment by warping allowed the creation of a single aggregate peak map containing all peak data from 
all samples. After peak detection on the aggregate map, the peak intensities were determined for each detected 
individual peak per run. The peak intensity data were further normalized using a set of five “house-keeping” pro-
teins (PF3D7_0406100, PF3D7_0520900, PF3D7_0624000, PF3D7_1115600 and PF3D7_1117700). The peptide 
identification was done by searching the MSE data against WT proteome to link identified peptides to their cor-
responding peak features. The following search criteria were used: a minimum of five fragment ions per peptide 
and a minimum of seven fragment ions per protein, a minimum of one peptide match per protein and a maxi-
mum of one missed trypsin cleavage. Furthermore, carbamidomethylation (Cys) and oxidation (M) were used 
as fixed and variable modifications respectively with a maximum of two missed cleavages allowed for search at 
the precursor mass tolerance of 10 ppm and product mass tolerance of 20 ppm. The peptides were auto-validated 
with maximum FDR of 4%. Principal components analysis (PCA) was performed, the generated feature dataset 
with sum intensity of all same peptide intensities was exported and further processed in Excel. The data from the 
individual injections were compared by paired 2-sided t-test with p < 0.05.
Comparative analysis for P. falciparum intensity measurements. Intensity measures are read from 
a pre-processed Excel spreadsheet. Measures for two P. falciparum strains are averaged (using numpy library 
method mean, http://www.numpy.org) and a standard deviation is computed (using the “std” method of the 
“numpy” library) along with the standard error of each set of measures (using the “sem” method of the “scipy” 
library (http://www.scipy.org)). A p-value is computed for each set of peptide measures and evaluated using a 
one-way ANOVA test where the null hypothesis that two or more groups have the same population mean (using 
the scipy stats package method statsf_oneway). Tryptic peptides are evaluated with preference being given to 
longer partially digested peptides over shorter, completely digested peptides that are fully contained within the 
partially digested peptide. Tryptic peptides are then further evaluated for fold change of intensity mean above 
a 25% difference threshold which further checked for statistical significance. All peptides not contained within 
another peptide have their means plotted on their respective proteins and proteins are grouped according to size, 
in 500 amino acid increments, and alphabetically by accession. Statistically significantly peptides (p-value <0.05) 
are highlighted with black asterisk above their position, peptides with fold change over the threshold of one 
strain over another are denoted with a grey asterisk above their position in each plot and peptides that are both 
statistically significant and have a fold change above the threshold are designated with a red asterisk. Reports of 
all peptides as well as peptides per protein summaries are produced.
Analysis of MSP1, MSP6 and MSP7 protein expression and processing by infrared fluorescence 
immunoblotting. Merozoite lysates from WT and LLM parasite lines were loaded at an approximated con-
centration of 1 × 107 parasites per lane on SDS-PAGE, 4–12% precast gels (Criterion XT, Bio-Rad, Hercules, CA) 
using a MES-based running buffer, and after electrophoretic separation, proteins were transferred to nitrocellu-
lose membranes in a semi-dry blotting system (Trans-Blot Turbo, Bio-Rad) following manufacturer’s instruc-
tions. Blocking, washes and antibody dilutions were prepared essentially as described elsewhere95. After the 
membranes were blocked, separate membranes were incubated for 1 h with either anti-MSP6EDK rat polyclonal 
or anti-MSP7 rabbit polyclonal serum at dilutions 1:500 and 1:2000, respectively. A second antibody incuba-
tion for an additional hour was performed by using anti-MSP142-FVO rabbit polyclonal serum (with anti-MSP6 
treated blots) or anti-MSP142-FVO mouse monoclonal antibody (mAb) 1G3 (with anti-MSP7 treated blots) at 
1:2000 dilution and 10 μg/ml, respectively. Bound antibodies were made detectable by incubation with a mix of 
IRDye 680RD goat anti-rabbit and IRDye 800CW goat anti-rat immunoglobulin secondary antibodies (LI-COR 
Biosciences, Lincoln, NE) at a dilution of 1:10000 each for 30 minutes (anti-MSP6 treated blots). Anti-MSP7 
treated blots required a mix of IRDye 680RD goat anti-mouse and IRDye 800CW goat anti-rabbit immunoglob-
ulin secondary antibodies. Digital band detection images were obtained by simultaneous membrane scanning at 
700 and 800 nm in an Odyssey infrared imaging system (LI-COR Biosciences). Densitometric analysis was done 
with the help of ImageJ software package (https://imagej.nih.gov/ij/index.html) including the entire lane(s) of 
interest without modification and pictures/plots prepared with office spreadsheet and graphic editor software 
(LibreOffice Calc, Inkscape and GIMP).
Experimental Design and Statistical Rationale. Genomic analysis of the WT and LLM lines used 
gDNA isolated from individual in vitro parasite cultures. Microarray studies used two paired biological replicates 
of LLM and WT merozoites and three or four technical replicates. MSE studies evaluated one pair of biological 
replicates that demonstrated significant differences in erythrocyte invasion rates to enable optimum measure-
ments of biological differences in protein abundance between LLM and WT parasite lines. The quantity of mero-
zoites was determined using a hemocytometer during cell-sieve purification. The biologically paired samples 
were each analyzed using three technical replicates on a Waters Synapt G2 for the comparative relative molar 
abundance study and statistical analyses used TransOmics™ software. The sample queue alternated the tech-
nical replicates for each biological sample. One biological sample from LLM was evaluated using five technical 
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replicates on a Waters Synapt G2 HDMI-MS and analyzed using PLGS version 2.5. The datasets generated during 
and/or analyzed during the current study are available as noted. The micrata discussed in this publication have 
been deposited, respectfully, in NCBI’s Gene Expression Omnibus97 and are accessible through GEO Series acces-
sion number GSE81818 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81818) or in Chorus and are 
accessible at the following sites:
https://chorusproject.org/pages/dashboard.html#/projects/my/1076
https://chorusproject.org/pages/dashboard.html#/projects/my/1086.
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